Clinical trial
A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing…
NCT00460473 · Hospira, now a wholly owned subsidiary of Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00460473 |
|---|---|
| Title | A Research Study to Evaluate the Effectiveness of Dexmedetomidine in Preventing Delirium After Hip Fracture Repair Surgery |
| Official title | A Phase III,Randomized, Double-Blind, Placebo-Controlled, Two-Arm Parallel, Multicenter Study Evaluating the Efficacy and Safety of Dexmedetomidine in the Prevention of Postoperative Delirium in Subjects Undergoing Surgery for Fractured Hip With General Anesthesia |
| Lead sponsor | Hospira, now a wholly owned subsidiary of Pfizer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Delirium |
| Intervention type | Drug |
| Interventions | Dexmedetomidine, Placebo |
| Enrollment | 52 |
| Start date | Apr 1, 2007 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Apr 16, 2007 |
| Last update posted | Jul 24, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: